Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in fertilization

Gynecological Endocrinology

Volumn 12, Issue 1, 1998, Pages 9-15

  Agrawal, R ^a,b   Conway, G S ^a   Engmann, L ^b   Bekir, J S ^b   Jacobs, H S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b London Women's Clinic   (United Kingdom)

Author keywords

Endometrium; Estradiol; FSH; hMG

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; ORGAFOL; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG FORMULATION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY DISEASE; OVARY FOLLICLE MATURATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0031951082     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599809024964     Document Type: Article

References (24)

1. Tan SL, Kingland C, Campbell S, et al. The long protocol of administration of GnRHa is superior to the short protocol of ovarian stimulation for in-vitro fertilisation. Fertil Steril 1992;57:810-14
2. Acosta AA, Bernardus RE, Jones JE, et al. The use of pure FSH alone or in combination for ovarian stimulation in IVF. Acta Eur Fertil 1985;16(2): 81-99
3. Bentick B, Shaw RW, Iffland CA, et al. A randomised comparative study of purified FSH and hMG after pituitary desensitisation with Buserelin for superovulation and in vitro fertilisation. Fertil Steril 1988;50(1):79-84
4. Edelstein MC, Brzyski RG, Jones GS, et al. Equivalency of human menopausal gonadotrophin and follicle-stimulating hormone after GnRH agonist supression. Fertil Steril 1990;53(1):103-6
5. Daya S. Follicular stimulating hormone versus human menopausal gonadotrophin in in vitro fertilisation, a meta-analysis. Horm Res 1995;43(5): 224-9
6. Daya S, Gumby J, Hughes G, et al. Randomized control trial of FSH versus hMG in in vitro fertilisation. Hum Reprod 1995;10(6):392-6
7. Diedrich K, Diedrich C, Van der Ven H, et al. Ovarian stimulation using pure FSH in an IVF programme. Hum Reprod 1988;10 (Suppl 2):23-8
8. Duijkers IJM, Vemer HM, Hollanders JMG, et al. Different follicle stimulating hormone/luteinizing hormone ratios for ovarian stimulation. Hum Reprod 1993;8:1387-91
9. Fried GM, Harlin J, Csemiczky G, et al. Controlled ovarian stimulation using highly purified FSH results in a lower serum estradiol profile in the follicular phase as compared with hMG. Hum Repro 1996;11(3):474-7
10. Hull MGR, Armatage Bentick B, Shaw RW, et al. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotrophin after pituitary desensitization with Buserelin for superovulation and in vitro fertilisation. Fertil Steril 1988;50:79-84
11. Hull MG, Armatage RJ, McDermott A. Use of FSH alone (urofollitrophin) to stimulate the ovaries for assisted conception after pituitary desensitisation. Fertil Steril 1994;62(5):997-1003
12. Hwang FR, Chang MY, Soong YK. Gonadotrophin stimulation after pituitary desensitisation with leuprolide acetate, comparison of FSH/hMG and hMG alone cycles - a study of 166 cases. Chang Keng I Hsueh 1993;16(4):223-30
13. Scoccia B, Blumenthal P, Wagner C. Comparison of urinary human follicular stimulating hormone and human menopausal gonadotrophin on ovarian stimulation in an in vitro fertilisation programme. Fertil Steril 1987;48:446-9
14. Tanbo T, Olav Dale P, Kjekshus E, et al. Stimulation with human menopausal gonadotrophin versus follicle stimulating hormone after pituitary suppression in polycystic ovary syndrome. Fertil Steril 1990;53(5):798-803
15. Torok A, Hamoril M, Tunneberg HR, et al. Comparative effects of human menopausal gonadotrophin or pure follicular stimulating gonadotrophin stimulation during supression with LHRH analogue. Hum Reprod 1991;6:922-4
16. Tepper R, Tadir Y, Kaplan-Kraicer R, et al. Comparison of different FSH and LH ratios for ovulation induction during in vitro fertilisation. Int J Fertil 1992;37(6):335-8
17. Westergaard LG, Erb K, Laursen S, et al. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod 1996;11:1209-13
18. Yang TS, Wang BC, Chang SP, et al. Comparison of hMG and FSH with GnRH desensitization for controlled ovarian hyperstimulation in in vitro fertilisation. Chung Hua I, Hsueh Tsa Chih Taipei 1995;55:452-6
19. Fevold HL. Synergism of follicle stimulating and luteinizing hormone in producing estrogen secretion. Endocrinology 1941;28:33-6
20. Shoham Z, Balen A, Patel AP, et al. Results of ovulation induction using human menopausal gonadotrophin or purified follicle-stimulating hormone in hypogonadotrophic hypogonadism patients. Fertil Steril 1991;56:1048-53
21. Weston AM, Zelinski-Wooten MB, Hutchison JS, et al. Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum Reprod 1996;11:608-13
22. Levy T, Orvieto R, Homburg R, et al. Severe OHSS despite low plasma estrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod 1996;11:1177-9
23. Shaker A, Bekir J, Pitroff R, et al. Administration of progesterone to hasten pituitary desensitisation after use of GnRH analogues in in vitro fertilisation - a prospective randomised study. Fertil Steril 1995;64(4):791-6
24. Schenker J, Weinstein D. Ovarian hyperstimulation syndrome - a current survey. Fertil Steril 1978;30(3):255-68